Kura Oncology Inc (NAS:KURA)
$ 8.86 -0.08 (-0.89%) Market Cap: 688.99 Mil Enterprise Value: 250.32 Mil PE Ratio: 0 PB Ratio: 1.63 GF Score: 29/100

Q4 2020 Kura Oncology Inc Earnings Call Transcript

Feb 24, 2021 / 01:00PM GMT
Release Date Price: $29.15 (-12.52%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Kura Oncology Fourth Quarter and Full Year 2020 Earnings Conference Call. (Operator Instructions) Please be reminded that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference to your speaker today, Pete De Spain. Please go ahead, sir.

Pete De Spain
Kura Oncology, Inc. - VP of IR & Corporate Communications

Great. Thank you, Victor. Good morning, and welcome to Kura Oncology's Fourth Quarter and Full Year 2020 Conference Call. Joining me on the call are Dr. Troy Wilson, our President and Chief Executive Officer; and Dr. Marc Grasso, our Chief Financial Officer and Chief Business Officer. Jim Basta, our Chief Legal Officer; Dr. Stephen Dale, our Chief Medical Officer; Kirsten Flowers, our Chief Commercial Officer; and Kathy Ford, our Chief Operating Officer, are also with us and available to answer questions.

Before I turn the call over to Dr. Wilson, I would like to remind you that today's call will include forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot